Are your appropriate asthma patients
looking to breathe better?
DUPIXENT may offer the results your
moderate-to-severe asthma patients seek
Choose DUPIXENT as an add-on therapy for your
moderate-to-severe eosinophilic or OCS-dependent asthma
patients aged 12+. Limitation of Use: DUPIXENT is not indicated
for the relief of acute bronchospasm or status asthmaticus.
Discover the
clinical data